The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

Medicare beneficiaries may pay less for 15 additional prescription drugs as early as 2027 as part of the next round of federal regulators' price negotiations with pharmaceutical manufacturers.

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Below is a review of novel drug and biological products approved by the Food and Drug Administration (FDA) in 2024. The list includes several groundbreaking therapies that are expected to change the ...

It continued, "Walgreens stands behind our pharmacists, dedicated healthcare professionals who live in the communities they serve, filling legitimate prescriptions for FDA-approved medications ...

Besides Ozempic and Wegovy, some of the other medications include Trelegy Ellipta, which treats asthma; Otezla, a psoriatic arthritis drug ... forcing seniors to skip prescriptions they can’t afford," ...

1 to release the list, but officials said the agency had routinely been ahead of schedule throughout the process. Coupled with the first 10 drugs that have already been negotiated for by Medicare ...

Together, these drugs represent one-third of Medicare's prescription ... and Otezla for psoriatic arthritis. Several cancer medications are also part of the expanded list, reflecting a focus ...

The list of 15 drugs in the next round is below, in the order provided by HHS. According to the health department, about 5.3 million people with Medicare prescription drug coverage used at least ...

In addition to Ozempic and Wegovy, some of the other medications include Trelegy Ellipta, which treats asthma; Otezla, a psoriatic arthritis drug; and several that treat different forms of cancer. The ...

Space limited. Register now. Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental Gayle Hays has paid north of $8,000 a year for her and her husband’s prescription ...